vimarsana.com

Page 7 - Clostridioides Difficile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Approves Poop-Based Pill to Treat Hardy Gut Infections

Fecal Microbiota Therapy Potentially Cost-effective at Preventing Recurrent CDI

The cost savings for health plans would increase if the therapy were used after the first recurrence of Clostridioides difficile infection (CDI).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.